Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Connor

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Pediatric Otorhinolaryngology|March 3, 2012
Noma in an Afghani child: a case reportJose Barrera, Matthew P Connor
Best Practice & Research. Clinical Haematology|March 25, 2021
CAR T in adult ALL: When and for whom?Matthew P Connor, Noelle V Frey
Ear, Nose, & Throat Journal|June 9, 2015
Maxillary myxoma: A case report and reviewMatthew P Connor, Michael Neilson, Cecelia E Schmalbach
The Laryngoscope|April 27, 2013
IMOUTA: a proposal for patient care handoffsMatthew P Connor, Anneke C Bush, Joseph Brennan
Current Opinion in Pharmacology|January 23, 2026
Advancements in targeted therapies for acute myeloid leukemiaMatthew P Connor, Adam Barsouk, Omar Elghawy, et al.
International Journal of Pediatric Otorhinolaryngology|December 3, 2014
The pediatric sedation unit: a prospective analysis of parental satisfactionMatthew P Connor, Gregory R Dion, Matthew Borgman, et al.
The Laryngoscope|September 12, 2012
Total airway reconstructionMatthew P Connor, Jose E Barrera, Robert Eller, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 30, 2013
Effect of vocal fold injection of cidofovir and bevacizumab in a porcine modelMatthew P Connor, Ammon Brown, Mitzi Palazzolo, et al.
The Laryngoscope|July 26, 2016
Effect of high-dose vocal fold injection of cidofovir and bevacizumab in a porcine modelMostafa M Ahmed, Matthew P Connor, Mitzi Palazzolo, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Pediatric Otorhinolaryngology|March 3, 2012
Noma in an Afghani child: a case reportJose Barrera, Matthew P Connor
Best Practice & Research. Clinical Haematology|March 25, 2021
CAR T in adult ALL: When and for whom?Matthew P Connor, Noelle V Frey
Ear, Nose, & Throat Journal|June 9, 2015
Maxillary myxoma: A case report and reviewMatthew P Connor, Michael Neilson, Cecelia E Schmalbach
The Laryngoscope|April 27, 2013
IMOUTA: a proposal for patient care handoffsMatthew P Connor, Anneke C Bush, Joseph Brennan
Current Opinion in Pharmacology|January 23, 2026
Advancements in targeted therapies for acute myeloid leukemiaMatthew P Connor, Adam Barsouk, Omar Elghawy, et al.
International Journal of Pediatric Otorhinolaryngology|December 3, 2014
The pediatric sedation unit: a prospective analysis of parental satisfactionMatthew P Connor, Gregory R Dion, Matthew Borgman, et al.
The Laryngoscope|September 12, 2012
Total airway reconstructionMatthew P Connor, Jose E Barrera, Robert Eller, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 30, 2013
Effect of vocal fold injection of cidofovir and bevacizumab in a porcine modelMatthew P Connor, Ammon Brown, Mitzi Palazzolo, et al.
The Laryngoscope|July 26, 2016
Effect of high-dose vocal fold injection of cidofovir and bevacizumab in a porcine modelMostafa M Ahmed, Matthew P Connor, Mitzi Palazzolo, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Pageof 2